Today, the prognosis for a patient with renal (kidney) cancer that has spread is very poor. Current treatment of metastasized kidney cancer only, on average, prolongs the life for the suffering patients with a few months, and often the therapy has severe side-effects. In experiments we have demonstrated that orellanine kills also kidney cancer cells and this will now be verified in patients.
- Bli medlem
- Om SwedenBIO